News
16 March 2023
What’s driving growth in the endocannabinoid therapeutics sector?
A range of factors are coming together to the sector's benefit.
13 February 2023
Significant Exits in the Global MedCan Market
A number of multi billion dollar exits in the sector show the viability and potential of early stage…
23 January 2023
Óskare’s 2022 market predictions come to fruition
Óskare Capital correctly called a range of key sector events in 2022.
30 November 2022
Family Offices Boost Private Equity Investment For 2023
North American family offices are increasing private equity portfolio allocation in 2023.
9 November 2022
How Medical Cannabis is Revolutionising Chronic Pain Management
Medical cannabis is providing doctors with a range of new treatments for chronic pain conditions.
3 November 2022
Germany’s plan for legalisation flips its current supply model
Germany’s plan for legalisation changes its current supply model
1 December 2021
Medical Cannabis EIS and SEIS Fund Launched
The MEDCAN Fund has launched today
28 January 2021
Guest Post: The Symbiosis of Regulation and Science – Óskare Capital SAS
ÓSKARE Fund I & Medical Cannabinoids